For the quarter ending 2025-09-30, VATE had $2,100K increase in cash & cash equivalents over the period. $19,000K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -9,600 | -46,800 |
| Step-up of equity method investments and unrealized gains on marketable securities | - | 4,900 |
| Share-based compensation expense | 700 | 1,500 |
| Depreciation and amortization (including amounts in cost of revenue) | 7,500 | 15,300 |
| Amortization of deferred financing costs and debt discount | 5,800 | 11,900 |
| Net loss on extinguishment or repurchase of debt | 0 | -300 |
| Loss from equity investees | 0 | -5,900 |
| Gains on lease modifications | 0 | 100 |
| Gains on investments | 5,200 | - |
| Deferred income tax expense | -200 | 100 |
| Other operating activities, net | 100 | -1,700 |
| Accounts receivable | 23,000 | 49,700 |
| Contract assets | -2,200 | -23,300 |
| Other current assets | 2,000 | -1,400 |
| Inventory | -2,600 | -100 |
| Other assets | -3,400 | -5,500 |
| Accounts payable | 19,700 | -5,100 |
| Accrued liabilities | 13,000 | 9,300 |
| Contract liabilities | 2,700 | 63,700 |
| Other current liabilities | -200 | -100 |
| Other liabilities | -3,000 | -7,000 |
| Cash provided by (used in) operating activities | 19,200 | 26,300 |
| Purchase of property, plant and equipment | 7,800 | 10,800 |
| Proceeds from disposal of property, plant and equipment | 200 | 1,200 |
| Loans to equity method investee | 0 | 0 |
| Purchase of investments | 0 | 300 |
| Proceeds from sale of investments | 2,900 | - |
| Cash paid for asset acquisitions | 200 | 300 |
| Other investing activities | 0 | 0 |
| Cash used in investing activities | -4,900 | -10,200 |
| Proceeds from rights offering and private placement, net of issuance costs | 0 | 0 |
| Proceeds from lines of credit, net of deferred financing costs | 14,700 | 71,200 |
| Payments on lines of credit | 25,000 | 86,800 |
| Proceeds from other debt obligations, net of deferred financing costs | 0 | 20,800 |
| Principal payments for other debt obligations | 1,100 | 36,200 |
| Dividend payments | 400 | 1,100 |
| Other financing activities | -100 | -100 |
| Cash (used in) provided by financing activities | -11,900 | -32,200 |
| Effects of exchange rate changes on cash, cash equivalents and restricted cash | -300 | 800 |
| Net decrease in cash and cash equivalents, including restricted cash | 2,100 | -15,300 |
| Cash and cash equivalents at beginning of period | 49,300 | - |
| Cash and cash equivalents at end of period | 36,100 | - |
INNOVATE Corp. (VATE)
INNOVATE Corp. (VATE)